WOONSOCKET, R.I. (AP) — CVS Caremark Corp.’s third-quarter earnings climbed 7 percent, as a long-term contract and acquisition boosted the pharmacy network claims it processed.
The Woonsocket, R.I., drugstore operator on Thursday also raised the low end of its full-year profit forecast, saying the Caremark pharmacy benefits business performed better than it expected during the quarter.
Shares of CVS Caremark rose $1.25, or 3.5 percent, to $37.02 in morning trading.
CVS Caremark reported net income of $868 million, or 65 cents per share, in the three months that ended Sept. 30. That compares with $809 million, or 59 cents per share, a year ago.
Adjusted earnings, which exclude amortization tied to acquisitions, were 70 cents per share, above analyst expectations for 67 cents, according to FactSet.
Revenue grew 12 percent to $26.67 billion. Analysts expected $26.76 billion.
CVS Caremark runs the second-largest chain of drugstores in the U.S., afterWalgreen Co. CVS had 7,304 stores at the end of the quarter, up from 7,152 a year ago. Its Caremark business is one of the largest pharmacy benefits managers, which handle drug benefits for health plan members and sponsors.
Revenue from its pharmacy services business, which includes Caremark, climbed 26 percent because of a long-term contract with health insurer Aetna Inc. and the acquisition of Universal American Corp.’s Medicare prescription drug business. Pharmacy network claims processed during the quarter rose 40 percent to 179.2 million.
Caremark profits have slumped in the last few years because of lost contracts, but CVS said it still expects profits will grow in 2012.
Pharmacy benefits managers are paid to reduce costs for health plan sponsors and members. CVS Caremark handles hundreds of millions of prescriptions ever year and uses its size to negotiate lower prices with manufacturers. During the third quarter its two largest competitors, Medco Health Solutions Inc. and Express Scripts Inc., agreed to combine. If regulators approve that deal, the resulting company would be about twice the size of Caremark.
Caremark is winning new business. On Jan. 1, CVS began administering Aetna’s retail pharmacy network and managing purchasing and prescription filling for Aetna’s mail-order and specialty pharmacy businesses. The 12-year contract is still ramping up, but it is expected to bring CVS Caremark $8.2 billion in revenue in 2011.
CVS also expanded its Medicare Part D business by acquiring the Universal American unit at the end of April for $1.25 billion, and it said that deal will bring $5.5 billion in additional revenue in 2012.
At the end of the quarter, CVS sold its TheraCom consulting business to AmerisourceBergen Corp. for $250 million. That deal closed Tuesday.
Total revenue from drugstores rose 4 percent to $14.69 billion. Revenue at stores open at least a year, a key measurement of retailer health, grew 2.3 percent. CVS said its business is not being affected by the dispute between Walgreen and Express Scripts, which may stop doing business together at the end of the year. However CVS said that if Walgreen stops participating in Express Scripts networks, it will be in position to benefit.
The company now expects 2011 adjusted earnings of $2.77 to $2.81 per share, compared with its previous forecast of $2.75 to $2.81 per share. Analysts had expected $2.76